Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 4/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 8/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | DHFR | P00374 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4895723 | 0.92 | CYP2A6 (0.50) | ALDH1A1CYP2A6SIGMAR1CYP1A2HPGD | |
| SCHEMBL4891192 | 0.90 | CYP2A6 (0.48) | ALDH1A1CYP2A6SIGMAR1CYP1A2HPGD | |
| SCHEMBL4894433 | 0.90 | SIGMAR1 (0.44) | ALDH1A1CYP2A6SIGMAR1CYP1A2HPGD | |
| SCHEMBL17933025 | 0.88 | CYP2A6 (0.50) | ALDH1A1CYP2A6SIGMAR1CYP1A2HPGD | |
| SCHEMBL18069064 | 0.87 | CYP2A6 (0.46) | ALDH1A1CYP2A6SIGMAR1CYP1A2HPGD | |
| SCHEMBL15768410 | 0.86 | ALDH1A1 (0.44) | ALDH1A1CYP2A6SIGMAR1CYP1A2HPGD | |
| SCHEMBL4894336 | 0.85 | SIGMAR1 (0.42) | ALDH1A1CYP2A6SIGMAR1CYP1A2L3MBTL1 | |
| SCHEMBL18134972 | 0.84 | CYP2A6 (0.58) | ALDH1A1CYP2A6SIGMAR1CYP1A2HPGD | |
| SCHEMBL17736288 | 0.83 | CYP2A6 (0.52) | ALDH1A1CYP2A6SIGMAR1CYP1A2HPGD | |
| SCHEMBL4921270 | 0.83 | SIGMAR1 (0.45) | ALDH1A1CYP2A6SIGMAR1CYP1A2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080058552-A1 | Novel Aromatic Tertiary Amines and Use Thereof as Organic Electronic Functional Material | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2008-03-06 | — | — | US | disclosed |
| EP-1829855-A1 | NOVEL AROMATIC TERTIARY AMINES AND UTILIZATION THEREOF AS ORGANIC ELECTRONIC FUNCTIONAL MATERIAL | BANDO CHEMICAL INDUSTRIES, LTD. (JP) | 2007-09-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080058552-A1 | Novel Aromatic Tertiary Amines and Use Thereof as Organic Electronic Functional Material | SLC18A1, PAH, TYR | ALDH1A1 463/4885CYP2A6 388/4885SIGMAR1 197/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.